Clinical Trials Logo

Clinical Trial Summary

In this randomized controlled clinical trial, 250 participants with female sexual dysfunction will be investigated regarding the effectiveness of an online intervention for improving sexual function, the unguided online intervention mylovia. Inclusion criteria are: female sex and female gender, age ≥18, diagnosed sexual dysfunction (ICD-11: HA00, HA01, HA02) or sexual pain disorder (ICD-11: HA20), low sexual functioning (<27 on the Female Sexual Function Index; FSFI), sufficient German skills, and consent to participation. Exclusion criteria are: biological, psychological or social factors that might interfere with study participation, and use of another digital intervention for sexual problems. Participants will be randomized and allocated to either an intervention group, receiving access to mylovia in addition to treatment as usual (TAU), or a control group, receiving information material about treatment and counseling options in addition to TAU. Primary endpoint will be sexual functioning assessed via FSFI, with three months post-allocation being the primary time point for assessment of effectiveness. Six months post allocation will be used as a timepoint for follow-up assessment of endpoints. Secondary endpoints will be sexual desire, sexual satisfaction, sexual pain, and general psychopathology.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06237166
Study type Interventional
Source Gaia AG
Contact Gitta A. Jacob, PhD
Phone +49.40.349930-374
Email gitta.jacob@gaia-group.com
Status Not yet recruiting
Phase N/A
Start date March 15, 2024
Completion date March 15, 2025

See also
  Status Clinical Trial Phase
Completed NCT05806424 - Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles
Completed NCT01364623 - PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women Phase 1
Recruiting NCT06060691 - the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction Phase 1
Recruiting NCT04419961 - Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester N/A
Completed NCT04122703 - Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction N/A
Recruiting NCT03498443 - Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
Completed NCT03232801 - A Mindfulness-based Intervention for Older Women With Low Sexual Desire N/A
Completed NCT04124640 - Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction.
Completed NCT00995072 - Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function N/A
Active, not recruiting NCT05168371 - Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction N/A
Recruiting NCT04384172 - Effect of Peripheral Neuromodulation on Vaginal Blood Flow N/A
Completed NCT03463707 - BP101 for Adults With Female Sexual Dysfunction Phase 3
Recruiting NCT01078077 - The Impact of a Topical Vasodilating Cream on Female Sexual Experience N/A
Completed NCT02229721 - Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women Phase 2
Completed NCT01724658 - Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women Phase 2
Completed NCT00479570 - Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction. Phase 2
Withdrawn NCT02862184 - Female Sexual Dysfunction, Risks and Outcomes (FSFI) N/A
Completed NCT01195701 - Clitoral Location in Relation to Sexual Function Using Pelvic Imaging N/A
Completed NCT04484753 - Validation of iPelvis App for Female Pelvic Floor Dysfunction N/A
Completed NCT03500146 - Sexual Function Trial of Overactive Bladder: Medication Versus PTNS